2018 ACR/ARHP Annual Meeting

October 19-24, 2018. Chicago, IL.

View by Number View by Title View Sessions

View by Date

Abstract Number: 238

IL Inhibitors Therapy in Rheumatic Diseases and the Risk of Malignancies: Systematic Review and Meta-Analysis of Rare Harmful Effects in Randomized Controlled Trials
Abstract Number: 239

Outcomes of Hospitalizations and the Temporal Trends in Mortality from Acute Myocardial Infarction in Patients with RA and FM during 2005 to 2015
Abstract Number: 240

Bi-Directional Associations between “Too Much Sitting” and Self-Reported Pain in Patients with Rheumatoid Arthritis
Abstract Number: 241

Is There a Relationship between Takotsubo Cardiomyopathy and Fibromyalgia? Insights from the National Inpatient Sample Database
Abstract Number: 242

DHEA Deficiency in Fibromyalgia
Abstract Number: 243

High Prevalence of Fibromyalgia Among Israel School Teachers
Abstract Number: 244

A Qualitative Study Mapping the Behaviour Change Techniques Used in a Practice-Based Fibromyalgia Self-Management Programme
Abstract Number: 245

Improvement in Fibromyalgia Symptoms and Skin Biopsy Results in Patients with Fibromyalgia and Small Fiber Neuropathy Treated with Intravenous Immune Globulin Infusion( IVIG)
Abstract Number: 246

Factors Associated with Disability in a Prospective Cohort of Complex Regional Pain Syndrome Type 1
Abstract Number: 247

Fibromyalgia Patients Often Receive Several Rheumatic Disease Diagnoses
Abstract Number: 248

The Emotional Quotient in Fibromyalgia Patients Is Similar to Rheumatic Disease Controls
Abstract Number: 249

Patients with Fibromyalgia May be Fearful of Developing Dementia Despite Lack of Concrete Evidence of Cognitive Decline
Abstract Number: 250

Fibromyalgia Patients Do Not Appear to Obsess about Their Symptoms Compared with Other Rheumatic Disease Patients
Abstract Number: 251

Using the Stroop Word Naming Test and the Mental Clutter Scale in Fibromyalgia Patients to Evaluate the Symptoms of Fibrofog. in Office Testing of Cognitive Complaints
Abstract Number: 252

Publication Bias Regarding Scientific Studies about Fibromyalgia

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].